Catamaran Corp (NASDAQ: SXCI) is one of 14 public companies in the “Managed Health Care” industry, but how does it weigh in compared to its peers? We will compare Catamaran Corp to similar companies based on the strength of its analyst recommendations, risk, earnings, profitability, dividends, valuation and institutional ownership.
This is a breakdown of current ratings for Catamaran Corp and its peers, as provided by MarketBeat.com.
|Sell Ratings||Hold Ratings||Buy Ratings||Strong Buy Ratings||Rating Score|
|Catamaran Corp Competitors||81||931||1473||24||2.57|
As a group, “Managed Health Care” companies have a potential downside of 1.85%. Given Catamaran Corp’s peers higher probable upside, analysts plainly believe Catamaran Corp has less favorable growth aspects than its peers.
Volatility & Risk
Catamaran Corp has a beta of -0.18, indicating that its stock price is 118% less volatile than the S&P 500. Comparatively, Catamaran Corp’s peers have a beta of 0.61, indicating that their average stock price is 39% less volatile than the S&P 500.
Valuation & Earnings
This table compares Catamaran Corp and its peers revenue, earnings per share (EPS) and valuation.
|Gross Revenue||NetIncome||Price/Earnings Ratio|
|Catamaran Corp Competitors||$50.73 billion||$1.52 billion||11.48|
Catamaran Corp’s peers have higher revenue and earnings than Catamaran Corp. Catamaran Corp is trading at a higher price-to-earnings ratio than its peers, indicating that it is currently more expensive than other companies in its industry.
This table compares Catamaran Corp and its peers’ net margins, return on equity and return on assets.
|Net Margins||Return on Equity||Return on Assets|
|Catamaran Corp Competitors||1.81%||11.04%||3.55%|
Insider and Institutional Ownership
90.7% of shares of all “Managed Health Care” companies are held by institutional investors. 2.6% of shares of all “Managed Health Care” companies are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.
Catamaran Corp peers beat Catamaran Corp on 7 of the 8 factors compared.
Catamaran Corp Company Profile
Catamaran Corporation (Catamaran) is a provider of pharmacy benefit management (PBM) services and healthcare information technology (HCIT) solutions to the healthcare benefit management industry. The Company operates in two segments: PBM and HCIT. The Company offers PBM services, which are marketed under the Catamaran PBM brand, and is engaged in owning and operating a network of mail and specialty pharmacies. In addition, the Company is a national provider of drug benefits to its customers under the federal government’s Medicare Part D program. The Company’s HCIT product offerings include a range of software products for managing prescription drug programs and for drug prescribing and dispensing. The Company’s customers include organizations in the pharmaceutical supply chain, such as pharmacy benefit managers, managed care organizations, self-insured employer groups, unions, third-party healthcare plan administrators, and state and federal government entities.
Receive News & Ratings for Catamaran Corp Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Catamaran Corp and related companies with MarketBeat.com's FREE daily email newsletter.